Related Experiment Video

Updated: Jun 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Directing systemic oncolytic viral delivery to tumors via carrier cells

Hiroshi Nakashima1, Balveen Kaur, E A Chiocca

  • 1Dardinger Laboratory for Neuro-oncology and Neurosciences, Department of Neurological Surgery, James Comprehensive Cancer Center, Columbus, OH 43210, United States.

Cytokine & Growth Factor Reviews
|March 16, 2010
PubMed

Insights

Cell-mediated delivery of oncolytic viruses (OVs) using stem cells offers a promising cancer therapy approach. This method enhances viral targeting and shields them from immune clearance, though challenges remain in carrier cell integration and OV replication.

Area of Science:

  • Oncology
  • Virology
  • Cell Biology

Background:

  • Systemic oncolytic virus (OV) administration faces challenges including immune clearance and off-target delivery.
  • Cell-mediated delivery using tumor-homing stem cells presents an alternative strategy for OV therapy.
  • Mesenchymal and neural stem cells are investigated as potential carriers for OVs due to their tumor-homing properties.

Purpose of the Study:

  • To review current approaches utilizing carrier cells for oncolytic virus delivery in cancer therapy.
  • To explore the potential of mesenchymal and neural stem cells in enhancing OV efficacy.
  • To identify and discuss the challenges associated with cell-mediated OV delivery systems.

Main Methods:

  • Review of existing literature on cell-mediated oncolytic virus delivery.
  • Analysis of studies investigating stem cell homing and OV payload capacity.
  • Discussion of the requirements for effective OV internalization and replication in both carrier and cancer cells.

Main Results:

  • Cell-mediated delivery can protect OVs from host immune responses.
  • Carrier cells can direct OVs towards tumor sites, improving targeting efficiency.
  • Successful OV therapy requires efficient viral internalization and replication within both carrier and target cancer cells.

Conclusions:

  • Cell-mediated OV delivery holds significant therapeutic potential for cancer treatment.
  • Overcoming challenges in cellular internalization, replication, and carrier cell integration is crucial for clinical success.
  • Further research is needed to optimize stem cell-based OV delivery systems for enhanced cancer therapy.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...